Evaluation of coagulopathy before and during induction chemotherapy for acute lymphoblastic leukaemia, including assessment of global clotting tests

por Burley, K, Salem, J, Phillips, T, Reilly-Stitt, C, Marks, D I, Tunstall, O, Moppett, J, Mumford, A, Bradbury, C A
Publicado 2017

PROTECT VIII Kids: BAY 94‐9027 (PEGylated Recombinant Factor VIII) safety and efficacy in previously treated children with severe haemophilia A

por Santagostino, Elena, Kenet, Gili, Fischer, Kathelijn, Biss, Tina, Ahuja, Sanjay, Steele, MacGregor, Martínez, M., Male, C., van Geet, C., Mondelaers, V., Kaleva, V., Stoyanova‐Deleva, A., Bobev, D., Blanchette, V., Zanon, E., Gagliano, F., Rageliene, L., Peters, M., Mlynarski, W., Badowska, W., Serban, M., Rusen, L., Uscatescu, V., Will, A., Payne, J., Tunstall, O., Kerlin, B., Gruppo, R., Eyster, M. E., Ducore, J., Schwartz, J.
Publicado 2020